ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,326.73
0.00%
Brent Oil
84.85
0.00%
Bitcoin
60,938.31
1.04%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Vir Biotechnology Inc (VIR) Share Price

VIR Vir Biotechnology Inc

8.76
-0.11 (-1.24%)
29 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Vir Biotechnology Inc NASDAQ:VIR NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.11 -1.24 8.76 8.75 9.16 8.97 8.76 8.92 2,361,142 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 86.18M -615.06M -4.5206 -1.97 1.21B
 Type  Size  Price  Time  Units 
 9 4 8.75 23:56:39 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore VIR News
26/06/202413:05BWVir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection
12/06/202421:00EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
05/06/202411:04EDGAR2Form 8-K - Current report
05/06/202410:30BWTobevibart Monotherapy and Combination Therapy with Elebsiran Achieved High Virologic Response and ALT Normalization in People Living with the Hepatitis Delta Virus After 12 and 24 Weeks of Treatment
03/06/202417:13EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
03/06/202416:57EDGAR2Form 3 - Initial statement of beneficial ownership of securities
31/05/202419:43EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
23/02/201920:48PBBStanley Wootliff Supporters118
13/07/201214:39PBBViridas - the Russians are coming!!1,324
24/02/201212:30PBBVIRIDAS : The basic essentials of VIR at present634
26/09/201113:37PBBCharts etc....6
31/05/201117:37PBBVIRIDAS : Basic Essentials of VIR at present3
31/05/201117:23PBBVIRIDAS : "Just the facts marm"1
29/09/201017:28PBBVIRIDAS Jatropha plantations in Brazil for biodiesel30
Data Downloads for VIR

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Vir Biotechnology Inc Articles